7 unknown. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 7 |
| Phase 3 | 1 | Unknown 1 |
Follow Muscle Hypertonia: new trials by email Literature Review of Muscle Hypertonia trials Research Report on Muscle Hypertonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy Magnetic Spinal Stimulation - Spastic Cerebral Palsy, Dysarthria | Phase 2 / Phase 3 | Unknown | Sociedad Argenttina de Neuromodulación | 20 | 2024-11-18 | 2023-11-21 |
| INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT) IncobotulinumtoxinA 100 UNT [Xeomin] - Spastic Cerebral Palsy | Phase 2 | Unknown | Universita di Verona | 30 | 2022-06-01 | 2022-04-22 |
| Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity SL-1002, Placebo - Spasticity | Phase 2 | Unknown | Saol Therapeutics Inc | 32 | 2022-04-22 | 2023-09-06 |
| Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy MNC, MSC, Control - Cerebral Palsy, Spastic | Phase 2 | Unknown | Tehran University of Medical Sciences | 108 | 2017-07-23 | 2019-01-08 |
| The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients Avidekel oil, Enriched Avidekel oil - Spasticity, Dystonia | Phase 2 | Unknown | Wolfson Medical Center | 40 | 2015-07-01 | 2015-08-18 |
| Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis Placebo injection, Botulinum toxin injection, Placebo injection and botulinum toxin injection - Hemiparesis After Stroke, Traumatic Brain Injury | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 66 | 2014-12-01 | 2017-04-19 |
| Use of Cannabinoids in Patients With Multiple Sclerosis Sativex - Multiple Sclerosis | Phase 2 | Unknown | S. Andrea Hospital | 20 | 2005-07-01 | 2005-11-29 |
Muscle Spasticity (7) · Cerebral Palsy (4) · Brain Injuries, Traumatic (1) · Dysarthria (1) · Dystonia (1) · Multiple Sclerosis (1)
Muscular Diseases (7) · Musculoskeletal Diseases (7) · Nervous System Diseases (7) · Neurologic Manifestations (7) · Neuromuscular Manifestations (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Brain Diseases (5) · Central Nervous System Diseases (5) · Brain Damage, Chronic (4) · Articulation Disorders (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Injuries (1)
Botulinum Toxins (1) · Transcutaneous Electric Nerve Stimulation (1) · incobotulinumtoxinA (1) · nabiximols (1)
Assistance Publique - Hôpitaux de Paris (1) · S. Andrea Hospital (1) · Saol Therapeutics Inc (1) · Sociedad Argenttina de Neuromodulación (1) · Tehran University of Medical Sciences (1) · Universita di Verona (1) · Wolfson Medical Center (1)
Argentina (1) · France (1) · Iran (1) · Israel (1) · Italy (1) · United States (1)
Ali Reza Moaeidi, MD (1) · Amirali Hamidieh, MD (1) · Anahita Majma, MD (1) · Carlo Pozzilli, MD (1) · Hadi Montazerlotfelahi, MD (1) · Juan Carlos M Andreani, MD (1) · Mahmoudreza Ashrafi, MD (1) · Maurizio Inghilleri, MD (1) · Tommaso Tufo, MD (1) · Werner Braunsdorf, MD (1) · Wojciech Maksymowicz, MD (1)
PMID 12529557, PMID 15037681, PMID 16108461, PMID 19416339, PMID 24100132, PMID 24909743, PMID 25593079, PMID 34362453, PMID 34438333, PMID 35351020, PMID 42156830